CAMP4 Therapeutics Corporation ( CAMP) - Stock Earnings
CAMP Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q4 | -40.3 million USD | 348000 USD |
| 2026Q1 | -18.3 million USD | 1.3 million USD |
| 2026Q2 | -33.5 million USD | 1.8 million USD |
| 2026Q4 Est. | — | — |
| 2027Q1 Est. | — | — |
| 2027Q2 Est. | — | — |
CAMP Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -49.3 million USD | 350000 USD |
| 2024 | -51.8 million USD | 652000 USD |
| 2025 | -80.4 million USD | 3.5 million USD |
| 2026 Est. | — | — |
CAMP
Price: $3.47
52 week price:
Earnings Per Share: -2.31 USD
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 144300
Ebitda: 23.8 millionMarket Capitalization: 251.0 million